Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer

Xuebin Yang, Yongjun Liu, Haresh Mani, Jeffrey Olson, Gary Clawson, Carla Caruso, Richard Bruggeman, John M. Varlotto, Dani S. Zander, Negar Rassaei

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A recent multicenter study led by our institution demonstrated that local recurrence of non-small cell lung cancer (NSCLC) was significantly more frequent in patients with diabetes, raising the possibility of different tumor biology in diabetics. Epithelial-to-mesenchymal transition (EMT) plays a key role in local tumor recurrence and metastasis. In the present study, we investigated differences of tumor microenvironment between patients with and without diabetes by examining expression of EMT markers. Seventy-nine NSCLC patients were selected from the cohort of our early multicenter study. These patients were classified into 4 groups: 39 with adenocarcinoma with (n = 19) and without (n = 20) diabetes, and 40 with squamous cell carcinoma with (n = 20) and without (n = 20) diabetes. Immunohistochemical expression of eight EMT markers was analyzed, including transforming growth factor-beta (TGF-β), epidermal growth factor receptor (EGFR), insulin-like growth factor 1 receptor (IGF-1R), vimentin, E-cadherin, N-cadherin, HtrA1, and beta-catenin. Five markers (E-cadherin, HtrA1, TGF-β, IGF-1R and vimentin) demonstrated significantly higher expression in diabetics than in non-diabetics in both histology types. N-cadherin had higher expression in diabetics, though the difference did not reach statistical significance. EGFR showed a higher expression in diabetics in squamous cell carcinoma only. Beta-catenin was the only marker with no difference in expression between diabetics versus non-diabetics. Our findings suggest that diabetes is associated with enhanced EMT in NSCLC, which may contribute to growth and invasiveness of NSCLC.

Original languageEnglish (US)
Pages (from-to)73-77
Number of pages5
JournalPathology and Oncology Research
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Epithelial-Mesenchymal Transition
Cadherins
Non-Small Cell Lung Carcinoma
Somatomedin Receptors
Recurrence
beta Catenin
Vimentin
Epidermal Growth Factor Receptor
Transforming Growth Factor beta
Multicenter Studies
Squamous Cell Carcinoma
Tumor Microenvironment
Neoplasms
Histology
Adenocarcinoma
Neoplasm Metastasis
Growth

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

Yang, Xuebin ; Liu, Yongjun ; Mani, Haresh ; Olson, Jeffrey ; Clawson, Gary ; Caruso, Carla ; Bruggeman, Richard ; Varlotto, John M. ; Zander, Dani S. ; Rassaei, Negar. / Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer. In: Pathology and Oncology Research. 2017 ; Vol. 23, No. 1. pp. 73-77.
@article{e54c156d846d41f9ac620cfbf2c2a5ed,
title = "Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer",
abstract = "A recent multicenter study led by our institution demonstrated that local recurrence of non-small cell lung cancer (NSCLC) was significantly more frequent in patients with diabetes, raising the possibility of different tumor biology in diabetics. Epithelial-to-mesenchymal transition (EMT) plays a key role in local tumor recurrence and metastasis. In the present study, we investigated differences of tumor microenvironment between patients with and without diabetes by examining expression of EMT markers. Seventy-nine NSCLC patients were selected from the cohort of our early multicenter study. These patients were classified into 4 groups: 39 with adenocarcinoma with (n = 19) and without (n = 20) diabetes, and 40 with squamous cell carcinoma with (n = 20) and without (n = 20) diabetes. Immunohistochemical expression of eight EMT markers was analyzed, including transforming growth factor-beta (TGF-β), epidermal growth factor receptor (EGFR), insulin-like growth factor 1 receptor (IGF-1R), vimentin, E-cadherin, N-cadherin, HtrA1, and beta-catenin. Five markers (E-cadherin, HtrA1, TGF-β, IGF-1R and vimentin) demonstrated significantly higher expression in diabetics than in non-diabetics in both histology types. N-cadherin had higher expression in diabetics, though the difference did not reach statistical significance. EGFR showed a higher expression in diabetics in squamous cell carcinoma only. Beta-catenin was the only marker with no difference in expression between diabetics versus non-diabetics. Our findings suggest that diabetes is associated with enhanced EMT in NSCLC, which may contribute to growth and invasiveness of NSCLC.",
author = "Xuebin Yang and Yongjun Liu and Haresh Mani and Jeffrey Olson and Gary Clawson and Carla Caruso and Richard Bruggeman and Varlotto, {John M.} and Zander, {Dani S.} and Negar Rassaei",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/s12253-016-0086-1",
language = "English (US)",
volume = "23",
pages = "73--77",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "1",

}

Yang, X, Liu, Y, Mani, H, Olson, J, Clawson, G, Caruso, C, Bruggeman, R, Varlotto, JM, Zander, DS & Rassaei, N 2017, 'Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer', Pathology and Oncology Research, vol. 23, no. 1, pp. 73-77. https://doi.org/10.1007/s12253-016-0086-1

Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer. / Yang, Xuebin; Liu, Yongjun; Mani, Haresh; Olson, Jeffrey; Clawson, Gary; Caruso, Carla; Bruggeman, Richard; Varlotto, John M.; Zander, Dani S.; Rassaei, Negar.

In: Pathology and Oncology Research, Vol. 23, No. 1, 01.01.2017, p. 73-77.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer

AU - Yang, Xuebin

AU - Liu, Yongjun

AU - Mani, Haresh

AU - Olson, Jeffrey

AU - Clawson, Gary

AU - Caruso, Carla

AU - Bruggeman, Richard

AU - Varlotto, John M.

AU - Zander, Dani S.

AU - Rassaei, Negar

PY - 2017/1/1

Y1 - 2017/1/1

N2 - A recent multicenter study led by our institution demonstrated that local recurrence of non-small cell lung cancer (NSCLC) was significantly more frequent in patients with diabetes, raising the possibility of different tumor biology in diabetics. Epithelial-to-mesenchymal transition (EMT) plays a key role in local tumor recurrence and metastasis. In the present study, we investigated differences of tumor microenvironment between patients with and without diabetes by examining expression of EMT markers. Seventy-nine NSCLC patients were selected from the cohort of our early multicenter study. These patients were classified into 4 groups: 39 with adenocarcinoma with (n = 19) and without (n = 20) diabetes, and 40 with squamous cell carcinoma with (n = 20) and without (n = 20) diabetes. Immunohistochemical expression of eight EMT markers was analyzed, including transforming growth factor-beta (TGF-β), epidermal growth factor receptor (EGFR), insulin-like growth factor 1 receptor (IGF-1R), vimentin, E-cadherin, N-cadherin, HtrA1, and beta-catenin. Five markers (E-cadherin, HtrA1, TGF-β, IGF-1R and vimentin) demonstrated significantly higher expression in diabetics than in non-diabetics in both histology types. N-cadherin had higher expression in diabetics, though the difference did not reach statistical significance. EGFR showed a higher expression in diabetics in squamous cell carcinoma only. Beta-catenin was the only marker with no difference in expression between diabetics versus non-diabetics. Our findings suggest that diabetes is associated with enhanced EMT in NSCLC, which may contribute to growth and invasiveness of NSCLC.

AB - A recent multicenter study led by our institution demonstrated that local recurrence of non-small cell lung cancer (NSCLC) was significantly more frequent in patients with diabetes, raising the possibility of different tumor biology in diabetics. Epithelial-to-mesenchymal transition (EMT) plays a key role in local tumor recurrence and metastasis. In the present study, we investigated differences of tumor microenvironment between patients with and without diabetes by examining expression of EMT markers. Seventy-nine NSCLC patients were selected from the cohort of our early multicenter study. These patients were classified into 4 groups: 39 with adenocarcinoma with (n = 19) and without (n = 20) diabetes, and 40 with squamous cell carcinoma with (n = 20) and without (n = 20) diabetes. Immunohistochemical expression of eight EMT markers was analyzed, including transforming growth factor-beta (TGF-β), epidermal growth factor receptor (EGFR), insulin-like growth factor 1 receptor (IGF-1R), vimentin, E-cadherin, N-cadherin, HtrA1, and beta-catenin. Five markers (E-cadherin, HtrA1, TGF-β, IGF-1R and vimentin) demonstrated significantly higher expression in diabetics than in non-diabetics in both histology types. N-cadherin had higher expression in diabetics, though the difference did not reach statistical significance. EGFR showed a higher expression in diabetics in squamous cell carcinoma only. Beta-catenin was the only marker with no difference in expression between diabetics versus non-diabetics. Our findings suggest that diabetes is associated with enhanced EMT in NSCLC, which may contribute to growth and invasiveness of NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=84978066094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978066094&partnerID=8YFLogxK

U2 - 10.1007/s12253-016-0086-1

DO - 10.1007/s12253-016-0086-1

M3 - Article

C2 - 27411924

AN - SCOPUS:84978066094

VL - 23

SP - 73

EP - 77

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 1

ER -